compound tirzepatide shortage The FDA says the Zepbound is over. That's rattling the weight loss industry 1 and GIP therapy FDA says this weight loss

As a result FDA paused the end of the shortage and announced it was reconsidering its position

Its just the science for me, calories in versus calories out, she explained

The concept is that patients could achieve significant weight loss on higher doses and then step down to 4mg to maintain results with fewer side effects

As insulin resistance improves and weight decreases, many women notice: More regular menstrual cycles Improved or restored ovulation Reduced acne and excess hair growth Better energy and mood balance Lower risk of developing Type 2 diabetes This approach aligns with comprehensive OBGYN care that treats interconnected hormonal and metabolic factors together